Burden of multidrug-resistant bacteria among HIV-positive individuals in Ethiopia: A systematic review and meta-analysis.

Muluneh Assefa, Azanaw Amare, Mitkie Tigabie, Getu Girmay, Abebaw Setegn, Yenesew Mihret Wondmagegn, Mebratu Tamir, Debaka Belete, Melak Aynalem, Teshome Belachew, Sirak Biset
Author Information
  1. Muluneh Assefa: Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. ORCID
  2. Azanaw Amare: Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
  3. Mitkie Tigabie: Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
  4. Getu Girmay: Department of Immunology and Molecular Biology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
  5. Abebaw Setegn: Department of Medical Parasitology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
  6. Yenesew Mihret Wondmagegn: Department of Medical Parasitology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
  7. Mebratu Tamir: Department of Medical Parasitology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
  8. Debaka Belete: Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
  9. Melak Aynalem: Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
  10. Teshome Belachew: Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
  11. Sirak Biset: Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. ORCID

Abstract

BACKGROUND: Multidrug-resistant (MDR) bacteria are a significant cause of severe infections, particularly in human immunodeficiency virus (HIV)-positive individuals because of their weakened immunity. Since there was no previous pooled representative data regarding the MDR bacteria among HIV-positive individuals in Ethiopia, this systematic review and meta-analysis is required.
METHODS: This study was conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A literature search was performed using PubMed, Medline, EMBASE, Google Scholar, Hinari, Web of Science, Science Direct, and African Journals Online databases. Data were extracted using Microsoft Excel 2019 and analyzed using STATA version 11.0 software. A random-effects model was used to estimate the pooled effect size of outcome variables across studies with a 95% confidence interval. The I2 statistic was used to check for heterogeneity. The presence of publication bias was determined using a funnel plot and Egger's test with a p-value < 0.05 evidence of statistically significant bias.
RESULTS: The pooled prevalence of MDR was 58.02% (95% CI: 46.32-69.73%) with high heterogeneity (I2 = 97.1%, (p < 0.001). In subgroup analysis, the highest multi-drug resistance was observed in the Oromia region (80.95%), patients with multiple infections (82.35%), and studies identified both Gram-positive and Gram-negative bacteria (61.45%). Furthermore, the pooled prevalence of MDR bacteria colonizing HIV-positive individuals was 48.76%. Regarding MDR species, Enterococci (77.41%) and Pseudomonas spp. (84.60%) were commonly identified in individuals with HIV infection.
CONCLUSION: Our study indicates a high burden of MDR among HIV-positive individuals in Ethiopia. The Oromia region, HIV patients with multiple infections, Pseudomonas spp., and Enterococci showed the highest MDR in the subgroup analysis. Therefore, regional hospitals should implement strategies to tackle MDR such as vaccination program, appropriate use of antibiotics, and further study on the associated factors of MDR bacteria in HIV are required.

References

  1. Biomed Res Int. 2019 May 05;2019:8768439 [PMID: 31192259]
  2. Stat Med. 2002 Jun 15;21(11):1539-58 [PMID: 12111919]
  3. One Health. 2021 Jun 29;13:100286 [PMID: 34258373]
  4. BMC Public Health. 2014 Feb 20;14:185 [PMID: 24555580]
  5. Expert Rev Anti Infect Ther. 2022 Feb;20(2):139-146 [PMID: 34152887]
  6. SAGE Open Med. 2023 Jan 2;11:20503121221145569 [PMID: 36632083]
  7. Sci Rep. 2020 Jul 1;10(1):10790 [PMID: 32612139]
  8. PLOS Glob Public Health. 2022 Sep 12;2(9):e0000838 [PMID: 36962756]
  9. PLoS One. 2021 Jun 24;16(6):e0251727 [PMID: 34166383]
  10. Int J Microbiol. 2020 Oct 19;2020:8893266 [PMID: 33133192]
  11. Clin Microbiol Infect. 2021 Jun;27(6):846-853 [PMID: 33813126]
  12. Curr Opin Microbiol. 2020 Feb;53:51-60 [PMID: 32172183]
  13. PLoS One. 2020 Dec 7;15(12):e0243054 [PMID: 33284828]
  14. Biomed Res Int. 2022 Sep 5;2022:5419874 [PMID: 36105930]
  15. Am J Surg. 1994 Jan;167(1A):7S-10S; discussion 10S-11S [PMID: 8109689]
  16. Yale J Biol Med. 2017 Mar 29;90(1):135-145 [PMID: 28356901]
  17. Lancet. 2022 Feb 12;399(10325):629-655 [PMID: 35065702]
  18. Cell Mol Life Sci. 2021 Mar;78(6):2585-2606 [PMID: 33582841]
  19. AIDS Res Ther. 2021 Apr 21;18(1):19 [PMID: 33882946]
  20. Cell Microbiol. 2016 May;18(5):645-51 [PMID: 26945815]
  21. PLoS One. 2020 Dec 15;15(12):e0243479 [PMID: 33320909]
  22. New Microbes New Infect. 2020 Oct 17;38:100789 [PMID: 33224508]
  23. BMC Infect Dis. 2016 Sep 02;16:465 [PMID: 27590053]
  24. Infect Drug Resist. 2024 Jan 03;17:17-29 [PMID: 38192330]
  25. Pediatr Infect Dis J. 2021 Sep 1;40(9S):S50-S58 [PMID: 34448744]
  26. PLoS One. 2022 Mar 16;17(3):e0265271 [PMID: 35294487]
  27. Open Forum Infect Dis. 2022 Sep 17;9(10):ofac487 [PMID: 36225740]
  28. Lancet Glob Health. 2024 Feb;12(2):e201-e216 [PMID: 38134946]
  29. Biomed Res Int. 2016;2016:5371875 [PMID: 27314025]
  30. Pan Afr Med J. 2017 Feb 02;26:60 [PMID: 28451037]
  31. One Health. 2022 Apr 20;14:100390 [PMID: 35686143]
  32. Antibiotics (Basel). 2021 Jun 07;10(6): [PMID: 34200238]
  33. Lancet Public Health. 2022 Nov;7(11):e897-e913 [PMID: 36244350]
  34. Infect Drug Resist. 2021 Jan 29;14:277-302 [PMID: 33542636]
  35. HIV AIDS (Auckl). 2020 Nov 27;12:799-808 [PMID: 33273865]
  36. Expert Rev Anti Infect Ther. 2022 Feb;20(2):147-160 [PMID: 34225545]
  37. Am J Infect Control. 2019 Mar;47(3):323-333 [PMID: 30170767]
  38. Arch Gynecol Obstet. 2022 Sep;306(3):663-686 [PMID: 35032208]
  39. Infect Drug Resist. 2023 Jun 29;16:4227-4236 [PMID: 37404258]
  40. Biomed Res Int. 2023 Feb 6;2023:7310856 [PMID: 36794255]
  41. J Glob Antimicrob Resist. 2021 Sep;26:133-139 [PMID: 34129993]
  42. Access Microbiol. 2023 Aug 16;5(8): [PMID: 37691838]
  43. Acta Microbiol Immunol Hung. 2019 Dec 1;66(4):469-483 [PMID: 31198058]
  44. Lancet Infect Dis. 2002 Oct;2(10):628-35 [PMID: 12383613]
  45. Infect Drug Resist. 2021 Apr 22;14:1623-1633 [PMID: 33911886]
  46. PLoS One. 2018 May 10;13(5):e0196722 [PMID: 29746496]
  47. Infect Drug Resist. 2019 Dec 20;12:3903-3910 [PMID: 31908502]
  48. Int J Surg. 2010;8(5):336-41 [PMID: 20171303]

MeSH Term

Humans
Ethiopia
Drug Resistance, Multiple, Bacterial
HIV Infections
Anti-Bacterial Agents
Prevalence

Chemicals

Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0MDRbacteriaindividualsHIVpooledHIV-positiveusinginfectionsamongstudy095%significantEthiopiasystematicreviewmeta-analysisrequiredScienceusedstudiesI2heterogeneitybias<prevalencehighsubgroupanalysishighestOromiaregionpatientsmultipleidentifiedEnterococciPseudomonassppBACKGROUND:Multidrug-resistantcausesevereparticularlyhumanimmunodeficiencyvirus-positiveweakenedimmunitySincepreviousrepresentativedataregardingMETHODS:conductedbasedPreferredReportingItemsSystematicReviewsMeta-AnalysesPRISMAguidelinesliteraturesearchperformedPubMedMedlineEMBASEGoogleScholarHinariWebDirectAfricanJournalsOnlinedatabasesDataextractedMicrosoftExcel2019analyzedSTATAversion11softwarerandom-effectsmodelestimateeffectsizeoutcomevariablesacrossconfidenceintervalstatisticcheckpresencepublicationdeterminedfunnelplotEgger'stestp-value05evidencestatisticallyRESULTS:5802%CI:4632-6973%=971%p001multi-drugresistanceobserved808235%Gram-positiveGram-negative6145%Furthermorecolonizing4876%Regardingspecies7741%8460%commonlyinfectionCONCLUSION:indicatesburdenshowedThereforeregionalhospitalsimplementstrategiestacklevaccinationprogramappropriateuseantibioticsassociatedfactorsBurdenmultidrug-resistantEthiopia:

Similar Articles

Cited By